Talaneh, S., Hosein zadeh, A., & Jafari, B. (2018). Treatment of advanced medullary thyroid cancer with an alternating 5 FU-dacarbazine. International Pharmacy Acta, 1(1), 157–158. https://doi.org/10.22037/ipa.v1i1.20501